Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




PEPFAR and BD Improve African Blood Collection Safety

By LabMedica International staff writers
Posted on 18 Aug 2009
United States officials have signed a partnership agreement with Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA), launching an initiative to improve blood collection safety in clinics and hospitals in sub-Saharan Africa. More...
The aim of the pact is to protect healthcare personnel and patients in African countries from infectious agents such as human immunodeficiency virus (HIV) that are transmitted by blood.

A Memorandum of Understanding was signed in Washington on August 11, 2009 by Ambassador Elizabeth Bagley, the U.S. Department of State special representative for global partnerships (Washington DC, USA), and Gary M. Cohen, executive vice president of BD.

Safer blood collection has become critical in sub-Saharan nations and other emerging African countries, which are severely impacted by the HIV/AIDS pandemic. Access to HIV treatment in these countries significantly increased in recent years and consequently has expanded the quantity of blood drawing for HIV screening and monitoring tests.

The three-year initiative--which may be extended up to two additional years--is scheduled to begin in Kenya and expand to include up to four additional U.S. President's Emergency Plan for AIDS Relief (PEPFAR)-supported countries. It will ultimately support in-service training for as many as 10,000 healthcare workers. When fully implemented, the monitoring component of the initiative aims to track as many as two million blood-draws within each participating country.

''The program will help hospital and clinical personnel improve their blood-drawing procedures and specimen handling, processes that are critical to the proper management of HIV/AIDS patients,'' said the State Department (Washington DC, USA) release. In addition, "… [it] will help prevent needle stick injuries by establishing or enhancing needle stick-injury surveillance. These monitoring measures can identify practices that pose risks to health workers and patients.''

Ministries of Health in participating countries will develop individualized policies, guidelines, and standard operating procedures for blood drawing and specimen handling.

Related Links:
U.S. Global Partnership Initiative, the Department of State
Becton, Dickinson and Company
PEPFAR


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.